Neurona Therapeutics Overview
- Founded
-
2008
- Status
-
Private
- Employees
-
57
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$72M
- Investors
-
16
Neurona Therapeutics General Information
Description
Developer of cell-based therapies designed to treat intractable neurological diseases. The company's therapies generate specific types of nerve cells for targeted delivery into the injured nervous system, enabling physicians to accelerate their treatments for patients with significant unmet medical needs.
Contact Information
Website
www.neuronatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 170 Harbor Way
- South San Francisco, CA 94080
- United States
+1 (650) 000-0000
Neurona Therapeutics Timeline
Neurona Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series D) | 22-Dec-2022 | $72M | 00000 | 00000 | Completed | Pre-Clinical Trials |
| 9. Grant | 26-May-2022 | 000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 8. Later Stage VC | 05-May-2022 | 000.00 | Completed | Clinical Trials - Phase 1 | ||
| 7. Debt - PPP | 30-Apr-2020 | 00000 | 000.00 | Completed | Pre-Clinical Trials | |
| 6. Later Stage VC (Series C) | 25-Nov-2019 | 0000 | 000.00 | 00000 | Completed | Pre-Clinical Trials |
| 5. Grant | 31-Oct-2019 | 00.000 | 000.00 | Completed | Pre-Clinical Trials | |
| 4. Grant | 01-Oct-2018 | 00.000 | 000.00 | Completed | Startup | |
| 3. Later Stage VC (Series B) | 26-Feb-2018 | 0000 | 000.00 | 0000 | Completed | Pre-Clinical Trials |
| 2. Later Stage VC (Series A) | 28-Dec-2016 | $28.7M | $28.8M | 000.00 | Completed | Pre-Clinical Trials |
| 1. Angel (individual) | 14-Aug-2008 | $95K | $95K | Completed | Startup |
Neurona Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series B | 00,000,000 | 00.000000 | 00.0 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A | 31,911,913 | $0.000100 | $0.07 | $0.9 | $0.9 | 1x | $0.9 | 44.18% |
Neurona Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of cell-based therapies designed to treat intractable neurological diseases. The company's therapies generate
Drug Discovery
South San Francisco, CA
57
As of 2022
00000
0000
0000-00-00
00000000000
00000
000000
sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
San Carlos, CA
00
As of 0000
000.00
000
0000-00-00
00000000000
000.00
000000
ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
Tucson, AZ
00
As of 0000
000.00
0000
0000-00-00
000000&0
000.00
Add Comparison
Neurona Therapeutics Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CuraSen | Venture Capital-Backed | San Carlos, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Formerly VC-backed | Tucson, AZ | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000&0 | 00000 |
| 00000000 000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000&0 | 00000 |
Neurona Therapeutics Patents
Neurona Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023200389-A1 | Neural precursor cell populations and uses thereof | Pending | 08-Oct-2015 | 000000000 | |
| CA-3001316-A1 | Neural precursor cell populations and uses thereof | Pending | 08-Oct-2015 | 000000000 | |
| EP-3359647-A1 | Neural precursor cell populations and uses thereof | Pending | 08-Oct-2015 | 000000000 | |
| JP-7138959-B2 | Methods of generating neural progenitor cell populations | Active | 08-Oct-2015 | 000000000 | 0 |
| JP-2018529389-A | Neural progenitor cell populations and their use | Pending | 08-Oct-2015 | A61K35/30 |
Neurona Therapeutics Executive Team (11)
Neurona Therapeutics Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Arnold Kriegstein Ph.D | Neurona Therapeutics | Co-Founder, Board Member & Scientific Advisor | 000 0000 |
| Bradley Margus | Self | Board Member | 000 0000 |
| Cory Nicholas Ph.D | Neurona Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| David Goeddel Ph.D | The Column Group | Board Member | 000 0000 |
| Erica Whittaker Ph.D | Self | Board Member | 000 0000 |
Neurona Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Neurona Therapeutics Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Columbia University Endowment | Limited Partner | 000 0000 | 000000 0 | ||
| Euclidean Capital | Family Office | Minority | 000 0000 | 000000 0 | |
| Hartford HealthCare | Corporation | Minority | 000 0000 | 000000 0 | |
| Harvard University Endowment | Limited Partner | 000 0000 | 000000 0 |